These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 31600834)
1. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834 [TBL] [Abstract][Full Text] [Related]
2. Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis. Liu F; Wei L; Leow WQ; Liu SH; Ren YY; Wang XX; Li XH; Rao HY; Huang R; Wu N; Wee A; Zhao JM Front Med (Lausanne); 2022; 9():925357. PubMed ID: 35833109 [TBL] [Abstract][Full Text] [Related]
3. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451 [TBL] [Abstract][Full Text] [Related]
4. Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH. Naoumov NV; Brees D; Loeffler J; Chng E; Ren Y; Lopez P; Tai D; Lamle S; Sanyal AJ J Hepatol; 2022 Nov; 77(5):1399-1409. PubMed ID: 35779659 [TBL] [Abstract][Full Text] [Related]
5. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. Sanyal AJ; Williams SA; Lavine JE; Neuschwander-Tetri BA; Alexander L; Ostroff R; Biegel H; Kowdley KV; Chalasani N; Dasarathy S; Diehl AM; Loomba R; Hameed B; Behling C; Kleiner DE; Karpen SJ; Williams J; Jia Y; Yates KP; Tonascia J J Hepatol; 2023 Apr; 78(4):693-703. PubMed ID: 36528237 [TBL] [Abstract][Full Text] [Related]
12. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD. Brunt EM; Clouston AD; Goodman Z; Guy C; Kleiner DE; Lackner C; Tiniakos DG; Wee A; Yeh M; Leow WQ; Chng E; Ren Y; Boon Bee GG; Powell EE; Rinella M; Sanyal AJ; Neuschwander-Tetri B; Younossi Z; Charlton M; Ratziu V; Harrison SA; Tai D; Anstee QM J Hepatol; 2022 May; 76(5):1030-1041. PubMed ID: 35090960 [TBL] [Abstract][Full Text] [Related]
13. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
14. Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models. Wang XX; Jin R; Li XH; Yang Q; Teng X; Liu FF; Wu N; Rao HY; Liu F Front Med (Lausanne); 2023; 10():1172058. PubMed ID: 37332758 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time. Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569 [TBL] [Abstract][Full Text] [Related]